268 related articles for article (PubMed ID: 7967514)
1. A sensitive multilayer immunoalkaline phosphatase method for detection of P-glycoprotein in leukemic and tumor cells in the bone marrow.
Haddad G; Thorner PS; Bradley G; Dalton WS; Ling V; Chan HS
Lab Invest; 1994 Oct; 71(4):595-603. PubMed ID: 7967514
[TBL] [Abstract][Full Text] [Related]
2. Multidrug resistance in pediatric malignancies.
Chan HS; DeBoer G; Haddad G; Gallie BL; Ling V
Hematol Oncol Clin North Am; 1995 Apr; 9(2):275-318. PubMed ID: 7642465
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
[TBL] [Abstract][Full Text] [Related]
4. Multidrug drug resistance in pediatric sarcomas.
Chan HS; DeBoer G; Haddad G; Ling V
Hematol Oncol Clin North Am; 1995 Aug; 9(4):889-908. PubMed ID: 7490247
[TBL] [Abstract][Full Text] [Related]
5. A sensitive method for immunocytochemical detection of P-glycoprotein in multidrug-resistant human ovarian carcinoma cell lines.
Chan HS; Bradley G; Thorner P; Haddad G; Gallie BL; Ling V
Lab Invest; 1988 Dec; 59(6):870-5. PubMed ID: 2904510
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma.
Moss TJ; Reynolds CP; Sather HN; Romansky SG; Hammond GD; Seeger RC
N Engl J Med; 1991 Jan; 324(4):219-26. PubMed ID: 1985243
[TBL] [Abstract][Full Text] [Related]
7. Identification of drug-resistant myeloid leukemic cells by measurement of DNA content, nuclear area, and detection of P-glycoprotein.
Emura I; Naito M; Kakihara T; Wakabayashi M; Hayashi N; Chou T
Cancer; 1996 Mar; 77(5):878-87. PubMed ID: 8608478
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance. Clinical opportunities in diagnosis and circumvention.
Chan HS; DeBoer G; Thorner PS; Haddad G; Gallie BL; Ling V
Hematol Oncol Clin North Am; 1994 Apr; 8(2):383-410. PubMed ID: 7913705
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia.
Maslak P; Hegewisch-Becker S; Godfrey L; Andreeff M
Cytometry; 1994 Sep; 17(1):84-93. PubMed ID: 8001461
[TBL] [Abstract][Full Text] [Related]
10. Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells.
Wu CJ; Biernacki M; Kutok JL; Rogers S; Chen L; Yang XF; Soiffer RJ; Ritz J
Clin Cancer Res; 2005 Jun; 11(12):4504-11. PubMed ID: 15958636
[TBL] [Abstract][Full Text] [Related]
11. Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
Uckun FM; Stork L; Seibel N; Sarquis M; Bedros C; Sather H; Sensel M; Reaman GH; Gaynon PS
Clin Cancer Res; 2000 Aug; 6(8):3123-30. PubMed ID: 10955793
[TBL] [Abstract][Full Text] [Related]
12. Clinical approach to circumvention of multidrug resistance in refractory leukemic patients: association of cyclosporin A with etoposide.
Maia RC; Carriço MK; Klumb CE; Noronha H; Coelho AM; Vasconcelos FC; Ruimanek VM
J Exp Clin Cancer Res; 1997 Dec; 16(4):419-24. PubMed ID: 9505216
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program.
Willman CL
Semin Hematol; 1997 Oct; 34(4 Suppl 5):25-33. PubMed ID: 9408958
[TBL] [Abstract][Full Text] [Related]
14. Effects of multidrug resistance gene expression in acute erythroleukemia.
Mazzella FM; Kowal-Vern A; Shrit MA; Rector JT; Cotelingam JD; Schumacher HR
Mod Pathol; 2000 Apr; 13(4):407-13. PubMed ID: 10786807
[TBL] [Abstract][Full Text] [Related]
15. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
[TBL] [Abstract][Full Text] [Related]
16. Terminal deoxynucleotidyltransferase distribution in neoplastic and hematopoietic cells.
Greenwood MF; Coleman MS; Hutton JJ; Lampkin B; Krill C; Bolium FJ; Holland P
J Clin Invest; 1977 May; 59(5):889-99. PubMed ID: 265945
[TBL] [Abstract][Full Text] [Related]
17. Paucity of leukemic progenitor cells in the bone marrow of pediatric B-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapse.
Uckun FM; Gaynon PS; Stram DO; Sensel MG; Sarquis MB; Lazarus KH; Willoughby M
Clin Cancer Res; 1999 Sep; 5(9):2415-20. PubMed ID: 10499612
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome.
Filipits M; Suchomel RW; Zöchbauer S; Brunner R; Lechner K; Pirker R
Clin Cancer Res; 1997 Aug; 3(8):1419-25. PubMed ID: 9815827
[TBL] [Abstract][Full Text] [Related]
19. A unique human ovarian carcinoma cell line expressing CD34 in association with selection for multidrug resistance.
Minderman H; Vanhoefer U; Toth K; Minderman MD; Rustum YM
Cancer; 1996 Dec; 78(11):2427-36. PubMed ID: 8941015
[TBL] [Abstract][Full Text] [Related]
20. Biological characteristics and prognostic value of in vitro three-drug resistance to prednisolone, L-asparaginase, and vincristine in childhood acute lymphoblastic leukemia.
Hongo T; Yamada S; Yajima S; Watanabe C; Fujii Y; Kawasaki H; Yazaki M; Hanada R; Horikoshi Y
Int J Hematol; 1999 Dec; 70(4):268-77. PubMed ID: 10643153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
